[1] |
WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua.
Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855.
|
[2] |
LIU Yi, WU Jingfang, QIN Lin, CHEN Junmiao, ZHANG Juan, CHEN Hua, NING Xiao, CAO Jin.
Related Substances in Efavirenz Tablets Based on HPLC-TRIPLE QUAD-MS/MS Technology
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 749-754.
|
[3] |
ZHONG Xinru, YANG Deying, GUAN Tangming, CHEN Ju, JIANG Dongbo.
Research Progress in Adverse Reactions Caused by Obinutuzumab in the Treatment of Follicular Lymphoma
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 831-835.
|
[4] |
GAO Caiyun, WANG Boyuan, GAO Xiaojie.
Research Progress in Correlations between SGLT2 Inhibitors and Malignant Tumors
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 836-840.
|
[5] |
JING Tianshu, LU Guotao, WANG Shengfeng.
Risks of Pancreatic Adverse Events Associated with Tirzepatide: a Disproportionality Analysis Using Spontaneous Adverse Event Reporting System Data
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 669-673.
|
[6] |
ZHENG Guimei, XIE Zeyu, CHENG Xiaoling, LIU Jiang, ZHANG Yueyan, CAO Weiling.
One Case of Euglycemic Diabetic Ketoacidosis Caused by Metformin Hydrochloride and Empagliflozin Tablets(Ⅰ)
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 693-695.
|
[7] |
BAO Lei, GENG Zihan, CUI Xiaolan.
Therapeutic Effect of Shufeng Jiedu Capsules against Respiratory Syncytial Virus-Infected Pneumonia by Regulating AIM2 Inflammasome Pathway
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 495-500.
|
[8] |
CHEN Siyuan, ZHANG Yan, FENG Xue, ZHANG Caijuan, WANG Dunfang, LIU Haifan, LIU Bin, ZHU Lin, LIU Jianyao, LI Tao, YANG Weipeng.
Identification of Chemical Constituents and Determination of Multi-Component Content of Lianpo Drinking Water Decoction Based on LC-MS/MS Technology
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 554-559.
|
[9] |
CHEN Chen, ZHAO Xiaoyan, CAI Tong, PEI Yusheng.
Detection of Bacterial Endotoxin in Recombinant Follicle-Stimulating Hormone β Injection Using Gel-Clot Method and Recombinant C-Factor Method
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 372-376.
|
[10] |
RAO Ling, XU Tiantian, HE Chunyuan, WANG Fang, WANG Facai.
Screening of Biomarkers of Skin Toxicity of Ioxanol and Its Potential Targets Based on Lipidomics
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 403-409.
|
[11] |
WU Shiqi, SU Su, YAN Suying, ZHANG Qingxia.
Bleeding Induced by Rivaroxaban Combined with PK-DDI in Patients with Nonvalvular Atrial Fibrillation and Renal Insufficiency:a Retrospective Cohort Study
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 415-419.
|
[12] |
ZHU Zhipeng, LYU Qiang, YE Xiaofei, GUO Xiaojing.
Disproportionality of Adverse Events to KRAS G12C Inhibitors Based on the FAERS Database
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 297-304.
|
[13] |
JIA Zhichao, HU Siyuan, LI Ruiben, XU Yaqian.
Safety of Children’s Traditional Chinese Medicine Decoction Pieces in Clinical Application and Children’s Drug Development
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 324-328.
|
[14] |
TANG Qianhui, ZHU Ying, ZHANG Haoran, ZHANG Luyong, JIANG Zhenzhou.
Roles of Hepatocellular NF-κB Signaling Pathway in Triptolide-Induced Indirect Liver Injury
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 128-138.
|
[15] |
WANG Hongli, DU Juan, CAO Mengqi, ZHANG Luyong, JIANG Zhenzhou, HUANG Xin.
Effects of Triptolide on Secretion of Steroid Hormone in Primary Adrenocortical Cells
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 139-146.
|